BR9916860A - Método de reduzir colesterol do sangue e/outriglicerìdios do sangue em um indivìduo mamìfero,preparação em forma de unidade de dosagem, e,conjunto para administrar oralmente a mesma - Google Patents
Método de reduzir colesterol do sangue e/outriglicerìdios do sangue em um indivìduo mamìfero,preparação em forma de unidade de dosagem, e,conjunto para administrar oralmente a mesmaInfo
- Publication number
- BR9916860A BR9916860A BR9916860-0A BR9916860A BR9916860A BR 9916860 A BR9916860 A BR 9916860A BR 9916860 A BR9916860 A BR 9916860A BR 9916860 A BR9916860 A BR 9916860A
- Authority
- BR
- Brazil
- Prior art keywords
- blood
- preparation
- dosage unit
- glycerides
- same
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/05—Phenols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Obesity (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
"MéTODO DE REDUZIR COLESTEROL DO SANGUE E/OUTRIGLICERìDIOS DO SANGUE EM UM INDIVìDUO MAMìFERO,PREPARAçãO EM FORMA DE UNIDADE DE DOSAGEM,E,CONJUNTO PARA ADMINISTRAR ORALMENTE A MESMA".Colesterol do sangue e/ou triglicerídeos do sangue são reduzidosem um indivíduo marmífero administrando-se uma quantidadeeficaz de terc-butilhidroquinona ou um sal desta. O indivíduomamífero é de preferência humano. Adicionalmente, a preparaçãode terc-butilhidroquinona em forma de unidade de dosagem éfornecida para reduzir colesterol do sangue e/ou triglicerídeos dosangue. A preparação é vantajosamente projetada paraadministração oral.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/228,092 US6020383A (en) | 1999-01-11 | 1999-01-11 | Method for reducing blood cholesterol and/or blood triglycerides |
PCT/US1999/030369 WO2000041504A2 (en) | 1999-01-11 | 1999-12-17 | Use of tertbutylhydroquinone for lowering blood cholesterol and/or blood triblycerides |
Publications (1)
Publication Number | Publication Date |
---|---|
BR9916860A true BR9916860A (pt) | 2001-10-30 |
Family
ID=22855753
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR9916860-0A BR9916860A (pt) | 1999-01-11 | 1999-12-17 | Método de reduzir colesterol do sangue e/outriglicerìdios do sangue em um indivìduo mamìfero,preparação em forma de unidade de dosagem, e,conjunto para administrar oralmente a mesma |
Country Status (6)
Country | Link |
---|---|
US (1) | US6020383A (pt) |
EP (1) | EP1140051A2 (pt) |
JP (1) | JP2002534445A (pt) |
CN (1) | CN1333681A (pt) |
BR (1) | BR9916860A (pt) |
WO (1) | WO2000041504A2 (pt) |
Families Citing this family (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6616942B1 (en) * | 1999-03-29 | 2003-09-09 | Soft Gel Technologies, Inc. | Coenzyme Q10 formulation and process methodology for soft gel capsules manufacturing |
US6436406B1 (en) | 2000-06-15 | 2002-08-20 | A. Glenn Braswell | Compositions and methods for reducing or controlling blood cholesterol, lipoproteins, triglycerides and atherosclerosis |
US6623734B2 (en) * | 2000-06-22 | 2003-09-23 | Soft Gel Technologies, Inc. | Super absorption coenzyme Q10 |
US6855733B2 (en) * | 2001-01-24 | 2005-02-15 | Soft Gel Technologies, Inc. | Formulation and manufacturing process for coenzyme Q10 soft gel capsules |
US7148211B2 (en) * | 2002-09-18 | 2006-12-12 | Genzyme Corporation | Formulation for lipophilic agents |
US20080089877A1 (en) * | 2003-08-14 | 2008-04-17 | Udell Ronald G | Super Absorption Coenzyme Q10 |
EP1670325A1 (en) | 2003-09-29 | 2006-06-21 | Soft Gel Technologies, Inc. | SOLUBILIZED CoQ-10 |
US7169385B2 (en) * | 2003-09-29 | 2007-01-30 | Ronald G. Udell | Solubilized CoQ-10 and carnitine |
US8124072B2 (en) | 2003-09-29 | 2012-02-28 | Soft Gel Technologies, Inc. | Solubilized CoQ-10 |
JP2007515422A (ja) * | 2003-12-22 | 2007-06-14 | アルコン,インコーポレイテッド | 糖尿病性網膜症および黄斑変性における結晶腔形成の処置のための薬剤 |
TW200526224A (en) * | 2003-12-22 | 2005-08-16 | Alcon Inc | Short form c-Maf transcription factor antagonists for treatment of glaucoma |
PT1803468E (pt) * | 2003-12-22 | 2011-11-23 | Novartis Ag | Agentes para tratar a retinopatia glaucomatosa e a neuropatia óptica |
US20060115870A1 (en) * | 2004-03-30 | 2006-06-01 | Alcon, Inc. | High throughput assay for human Rho kinase activity |
US20080096238A1 (en) * | 2004-03-30 | 2008-04-24 | Alcon, Inc. | High throughput assay for human rho kinase activity with enhanced signal-to-noise ratio |
WO2005102345A1 (en) * | 2004-03-30 | 2005-11-03 | Alcon, Inc. | Use of rho kinase inhibitors in the treatment of hearing loss, tinnitus and improving body balance |
FR2868313B1 (fr) * | 2004-03-31 | 2008-08-15 | Servier Lab | Nouvelle association entre un compose heterocyclique et un agent antioxydant et les compositions pharmaceutiques qui les contiennent |
JP2007289001A (ja) * | 2004-05-10 | 2007-11-08 | Toyo Shinyaku:Kk | ポリフェノールを含有する食品 |
US7284385B2 (en) * | 2004-09-16 | 2007-10-23 | Hess Spencer W | Pre-dried air reactivation for diesel fuel heated dessicant reactivator |
US8300698B2 (en) * | 2006-10-23 | 2012-10-30 | Qualcomm Incorporated | Signalling of maximum dynamic range of inverse discrete cosine transform |
US8343541B2 (en) | 2007-03-15 | 2013-01-01 | Soft Gel Technologies, Inc. | Ubiquinol and alpha lipoic acid compositions |
TWI518094B (zh) | 2011-12-26 | 2016-01-21 | Univ Beijing Peking Wbl Biotech Co Ltd | One kind of derivatives of sterols, their preparation and use |
CN110585180A (zh) * | 2019-09-25 | 2019-12-20 | 中国热带农业科学院环境与植物保护研究所 | 一种治疗百草枯急性中毒特异性解毒药物 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2591105B1 (fr) * | 1985-12-11 | 1989-03-24 | Moet Hennessy Rech | Composition pharmaceutique, notamment dermatologique, ou cosmetique, a base de phases lamellaires lipidiques hydratees ou de liposomes contenant un retinoide ou un analogue structural dudit retinoide tel qu'un carotenoide. |
US5116629A (en) * | 1990-10-24 | 1992-05-26 | General Mills, Inc. | Processed meat products containing fish oils stabilized with fructose |
US5338549A (en) * | 1992-12-21 | 1994-08-16 | The Procter & Gamble Company | Powdered psyllium drink mix compositions containing antioxidant |
US5608095A (en) * | 1996-04-30 | 1997-03-04 | Hoechst Marion Roussel, Inc. | Alkyl-4-silyl-phenols and esters thereof as antiatherosclerotic agents |
CN1168693C (zh) * | 1996-11-20 | 2004-09-29 | 阿温蒂斯药物公司 | 用作抗氧化剂的取代的苯酚和苯硫酚 |
-
1999
- 1999-01-11 US US09/228,092 patent/US6020383A/en not_active Expired - Lifetime
- 1999-12-17 CN CN99815540A patent/CN1333681A/zh active Pending
- 1999-12-17 JP JP2000593127A patent/JP2002534445A/ja active Pending
- 1999-12-17 EP EP99966477A patent/EP1140051A2/en not_active Withdrawn
- 1999-12-17 WO PCT/US1999/030369 patent/WO2000041504A2/en not_active Application Discontinuation
- 1999-12-17 BR BR9916860-0A patent/BR9916860A/pt not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
EP1140051A2 (en) | 2001-10-10 |
WO2000041504A3 (en) | 2000-11-09 |
WO2000041504A2 (en) | 2000-07-20 |
US6020383A (en) | 2000-02-01 |
JP2002534445A (ja) | 2002-10-15 |
CN1333681A (zh) | 2002-01-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR9916860A (pt) | Método de reduzir colesterol do sangue e/outriglicerìdios do sangue em um indivìduo mamìfero,preparação em forma de unidade de dosagem, e,conjunto para administrar oralmente a mesma | |
US6221377B1 (en) | Administration media for analgesic, anti-inflammatory and anti-pyretic drugs containing nitrous oxide and pharmaceutical compositions containing such media and drugs | |
BR0015284A (pt) | Formulações de hidrocodona de liberação controlada | |
CO4970819A1 (es) | Tratamiento de disfuncion sexual femenina en una hembra humana | |
BR9306841A (pt) | Composição farmacêutica processo para proporcionar um tratamento anti-histamínico o qual não induz qualquer arritmia cardíaca significativa em um paciente ser humano e uso de uma composição para a mnaufactura de um medicamento para uso em um tratamento anti-histamínico | |
ES2178430T3 (es) | Utilizacion de composiciones farmaceuticas gelificables en parodontologia. | |
ES2134340T3 (es) | Uso de acido beta-hidroxi-beta-metilbutirico para promover la retencion de nitrogeno en los seres humanos. | |
ES2074698T3 (es) | Composicion oral para el tratamiento de enfermedades intestinales inflamatorias. | |
BR9815255A (pt) | Toxina de botulismo modificada, vacina oralcontra o botulismo, vacina oral contra umantìgeno selecionado e método para ministraroralmente um agente terapêutico a um animal | |
KR950703951A (ko) | 광학적으로 순수한 r-케토로락을 포함하는 조성물과 무통과 해열치료에 이를 사용하는 방법(antipyretic and analgesic methods and compositions containing optically pure r-ketorolac) | |
AR020803A1 (es) | Una composicion que comprende fexofenadina o una sal farmaceuticamente aceptable de la misma y el uso de la misma para la manufactura de unmedicamento | |
MY124465A (en) | Reduction of infarct volume using citicoline | |
HK1026637A1 (en) | Compositions for administering taxanes orally to human patients and their use | |
DE69133077D1 (de) | Herstellung von ST1435 enthaltenden pharmazeutischen Zusammensetzungen zur topischen Verwendung | |
WO2001012214A3 (en) | MYCOPHENOLATE MOFETIL IN ASSOCIATION WITH PEG-IFN-$g(a) | |
BRPI0409699A (pt) | métodos de indução do efeito diurético, de indução, manutenção ou restauração do efeito diurético de diurético não modificador de adenosina, de manutenção, restauração ou melhoria da função renal em paciente, de indução de diurese, de prevenção do inìcio de deficiência renal em paciente com sobrecarga de fluidos ou chf, de tratamento de paciente que sofre de chf e de melhoria dos resultados globais da saúde, composição farmacêutica e seus usos | |
BR0207866A (pt) | Uso de flumazenil na preparação de um medicamento para o tratamento da dependência de cocaìna | |
CA2373296C (en) | Combination of nicotinic acid or nicotinamide with riboflavin for the treatment of pruritus, itching and inflammation disorders | |
AR025549A1 (es) | Mofetil micofelonato en asociacion con peg-ifn-alfa | |
AR012638A1 (es) | Uso de pregnan-3-ol-20-onas para la manufactura de un medicamento util para proveer una terapia progestacional | |
KR890007728A (ko) | 진통제 제조방법 | |
ATE91890T1 (de) | Herstellung eines arzneimittels gegen arthritis und rheumatismus. | |
KR910009255A (ko) | 과트리글리세라이드혈증과, 콜레스테롤혈증, 저레벨의 hdl질환 및 아테롬성 동맥경화증 치료제로서 사용되는 2-(페녹시 프로파놀아미노)에톡시 페녹시아세트산 유도체 | |
KR950703958A (ko) | Hiv 감염증을 치료하기 위한,다른 비뉴클레오사이드 역 전사효소 억제제와 혼합된 bhap 화합물의 용도(use of bhap compounds in combination with other non-nucleoside reverse transcriptase inhibitors for the treatment of hiv infection) | |
KR890701111A (ko) | 사람의 이상지혈증의 치료방법 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B11A | Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing | ||
B11Y | Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette] |